Normal Aging Lung Cell Atlas (NALCA)
正常老化肺细胞图谱 (NALCA)
基本信息
- 批准号:10275008
- 负责人:
- 金额:$ 8.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-01-01 至 2022-12-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdultAgeAgingAlveolarAlveolar MacrophagesAtlasesB-LymphocytesBiologicalBiomedical EngineeringBirthCOVID-19 pandemicCell AgingCellsCharacteristicsChronic Obstructive Airway DiseaseChronic lung diseaseChronologyCodeCommunitiesComputational BiologyComputer AnalysisDataDevelopmentDiseaseDisease susceptibilityElderlyEndothelial CellsEnvironmental and Occupational ExposureEpidemiologyEpigenetic ProcessEpithelial CellsFibroblastsGene Expression ProfilingGenerationsGenetic TranscriptionGenomic InstabilityGenomicsGoblet CellsGonadal Steroid HormonesHumanImmune responseImmunohistochemistryIn Situ HybridizationIncidenceIndividualLifeLungLung diseasesLung infectionsMalignant NeoplasmsMalignant neoplasm of lungMessenger RNAMethylationMicroRNAsModelingMolecularMusNational Heart, Lung, and Blood InstituteNuclearOrganOutcomeParentsPathogenesisPlayPredispositionProteomicsPulmonary HypertensionResourcesRespiratory SystemRespiratory Tract InfectionsRoleSamplingSex DifferencesSmooth Muscle MyocytesStructureStructure of parenchyma of lungSystems BiologyT-LymphocyteTimeTissue EngineeringTissue-Specific Gene ExpressionUnited States National Institutes of HealthUntranslated RNAValidationWild Type MouseWomanWorkagedbasebiological sexcell typedetection of nutrientepigenomicsexhaustionexperienceexperimental studyfunctional disabilityhigh throughput technologyidiopathic pulmonary fibrosisintercellular communicationlaser capture microdissectionmacrophagemenmitochondrial dysfunctionmonocytemortalitymultidisciplinarymultiple omicsneutrophilnormal agingnovelproteostasispulmonary functionrespiratory smooth muscleresponsesexsexual dimorphismsingle-cell RNA sequencingstem cellssynergismtelomeretranscriptomics
项目摘要
PROJECT SUMMARY AND SUPPLEMENT TO U01
The overall objective of the ‘Normal Aging Lung Cell Atlas’ (NALCA), our response to RFA-HL-19-012
(Deciphering the Molecular Landscape of Lung Aging in Humans U01), is to generate a compendium of the
dynamic cell specific changes in mRNA, microRNA, and epigenetic marks that happen during lung aging with a
focus on single cells and the alveolar microenvironment. We plan to use this compendium to generate a dynamic
temporal regulatory model of normal human lung aging. To address this objective, we have assembled a
multidisciplinary group of experts in lung genomics, epigenomics, bioengineering, aging, alveolar development,
systems and computational biology. The premise of this proposal lies in the availability of resources, including
normal human lungs at different ages, aged wild-type and aging relevant genetically modified mice, unique
expertise in high throughput technologies including single cell RNAseq, laser capture microdissection,
methylation profiling, proteomics and tissue engineering, and proven track record in developmental of analytical
approaches that dissect temporal regulatory networks. This objective also largely benefits from synergisms with
other non-overlapping NIH-NHLBI and NIH-NIA projects headed by the coinvestigators on this proposal. We will
address the objectives of this application by the following specific aims: Aim 1: To identify cell and
microenvironment specific changes in coding and non-coding RNAs across human lung aging. Aim 2: To identify
key time points in lung aging using detailed temporal analysis of mouse lung aging. Aim 3: To develop a
comprehensive transcriptional dynamic regulatory multicellular model of lung aging. The completion of these
specific aims will lead to the generation of the Normal Lung Aging Cell Atlas – a resource for the scientific
community that will allow both better understanding of normal lung resident cell aging, as well as the role of aging
related mechanisms in other chronic lung diseases.
项目摘要和 U01 的补充
“正常衰老肺细胞图谱”(NALCA) 的总体目标,我们对 RFA-HL-19-012 的回应
(破译人类肺衰老的分子景观 U01),是为了生成一个纲要
肺衰老过程中 mRNA、microRNA 和表观遗传标记的动态细胞特异性变化
我们计划使用这个纲要来生成动态的单细胞和肺泡微环境。
为了实现这一目标,我们建立了一个正常人类肺部衰老的时间调节模型。
肺基因组学、表观基因组学、生物工程、衰老、肺泡发育等多学科专家组,
该提案的前提在于资源的可用性,包括
不同年龄的正常人肺,衰老的野生型和衰老相关的转基因小鼠,独特
高通量技术方面的专业知识,包括单细胞 RNAseq、激光捕获显微切割、
甲基化分析、蛋白质组学和组织工程,以及分析开发方面的良好记录
剖析时间调控网络的方法也很大程度上受益于与时域调控网络的协同作用。
由共同研究者领导的关于本提案的其他非重叠的 NIH-NHLBI 和 NIH-NIA 项目我们将进行。
通过以下具体目标来解决本申请的目标: 目标 1:识别细胞和
人类肺部衰老过程中编码和非编码 RNA 的微环境特异性变化。
使用小鼠肺衰老的详细时间分析来确定肺衰老的关键时间点 目标 3:开发一个模型。
肺衰老的综合转录动态调节多细胞模型的完成。
具体目标将导致正常肺衰老细胞图谱的生成——这是科学界的资源
社区将有助于更好地了解正常的肺常驻细胞衰老以及衰老的作用
其他慢性肺部疾病的相关机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAFTALI KAMINSKI其他文献
NAFTALI KAMINSKI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAFTALI KAMINSKI', 18)}}的其他基金
Integrating single-cell based transcriptomic signatures for identifying therapeutic targets of COPD
整合基于单细胞的转录组特征来识别 COPD 的治疗靶点
- 批准号:
10360807 - 财政年份:2022
- 资助金额:
$ 8.6万 - 项目类别:
Integrating single-cell based transcriptomic signatures for identifying therapeutic targets of COPD
整合基于单细胞的转录组特征来识别 COPD 的治疗靶点
- 批准号:
10540331 - 财政年份:2022
- 资助金额:
$ 8.6万 - 项目类别:
Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis
甲状腺激素信号传导对纤维化的上皮保护作用
- 批准号:
10063549 - 财政年份:2018
- 资助金额:
$ 8.6万 - 项目类别:
Epithelial Protective Effects of Thyroid Hormone Signaling in Fibrosis
甲状腺激素信号传导对纤维化的上皮保护作用
- 批准号:
10307633 - 财政年份:2018
- 资助金额:
$ 8.6万 - 项目类别:
Mir-29 mimicry as a therapy for pulmonary fibrosis
Mir-29拟态作为肺纤维化的治疗方法
- 批准号:
9534175 - 财政年份:2014
- 资助金额:
$ 8.6万 - 项目类别:
Mir-29 mimicry as a therapy for pulmonary fibrosis
Mir-29拟态作为肺纤维化的治疗方法
- 批准号:
9144911 - 财政年份:2014
- 资助金额:
$ 8.6万 - 项目类别:
Mir-29 mimicry as a therapy for pulmonary fibrosis
Mir-29拟态作为肺纤维化的治疗方法
- 批准号:
8931051 - 财政年份:2014
- 资助金额:
$ 8.6万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 8.6万 - 项目类别:
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 8.6万 - 项目类别:
Translational genomics in gout: From GWAS signal to mechanism
痛风的转化基因组学:从 GWAS 信号到机制
- 批准号:
10735151 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
检查全球预算收入计划对接受化疗的癌症患者提供的护理成本和质量的影响
- 批准号:
10734831 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别:
Influence of Particulate Matter on Fetal Mitochondrial Programming
颗粒物对胎儿线粒体编程的影响
- 批准号:
10734403 - 财政年份:2023
- 资助金额:
$ 8.6万 - 项目类别: